Teladoc says better healthcare access alone is not improving outcomes, as GLP-1 and other specialty drugs expose a wider care-management gap for health plans. T

Teladoc says better healthcare access alone is not improving outcomes, as GLP-1 and other specialty drugs expose a wider care-management gap for health plans. The company is expanding virtual chronic-care partnerships as insurers rethink how care is managed.